Id |
Subject |
Object |
Predicate |
Lexical cue |
p1_all0 |
80-190 |
Population |
denotes |
patients Egyptian Journal of Chest Diseases and Tuberculosis
Abstract
Middle East Respiratory Syndrome (MERS) |
p2_p0 |
109-140 |
Condition |
denotes |
Chest Diseases and Tuberculosis |
p2_p1 |
387-419 |
Condition |
denotes |
severe acute respiratory illness |
p1_all1 |
387-420 |
Outcome |
denotes |
severe acute respiratory illness. |
p1_all2 |
517-725 |
Population |
denotes |
intensive care unit (ICU) admitted patients with confirmed MERS-CoV infection.
Patients and methods: This study included 32 laboratory confirmed MERS corona virus infected patients who were admitted into ICU. |
p1_all3 |
781-818 |
Population |
denotes |
The mean age was 43.99 ± 13.03 years. |
p2_p2 |
798-817 |
Age |
denotes |
43.99 ± 13.03 years |
p1_all4 |
1109-1122 |
Outcome |
denotes |
main symptoms |
p1_all5 |
1157-1162 |
Outcome |
denotes |
fever |
p2_o10 |
1157-1162 |
Adverse-effects |
denotes |
fever |
p1_all6 |
1173-1178 |
Outcome |
denotes |
cough |
p2_o10 |
1173-1178 |
Physical |
denotes |
cough |
p1_all7 |
1189-1196 |
Outcome |
denotes |
dyspnea |
p2_o10 |
1189-1196 |
Adverse-effects |
denotes |
dyspnea |
p1_all8 |
1207-1218 |
Outcome |
denotes |
sore throat |
p2_o10 |
1207-1218 |
Adverse-effects |
denotes |
sore throat |
p1_all9 |
1226-1236 |
Outcome |
denotes |
runny nose |
p2_o10 |
1226-1236 |
Adverse-effects |
denotes |
runny nose |
p1_all10 |
1244-1250 |
Outcome |
denotes |
sputum |
p2_o10 |
1244-1250 |
Adverse-effects |
denotes |
sputum |
p1_all11 |
1258-1266 |
Outcome |
denotes |
headache |
p2_o10 |
1258-1266 |
Adverse-effects |
denotes |
headache |
p1_all12 |
1277-1284 |
Outcome |
denotes |
myalgia |
p2_o10 |
1277-1284 |
Adverse-effects |
denotes |
myalgia |
p1_all13 |
1295-1305 |
Outcome |
denotes |
chest pain |
p2_o10 |
1295-1305 |
Adverse-effects |
denotes |
chest pain |
p1_all14 |
1316-1326 |
Outcome |
denotes |
hemoptysis |
p2_o10 |
1316-1326 |
Adverse-effects |
denotes |
hemoptysis |
p1_all15 |
1337-1356 |
Outcome |
denotes |
nausea and vomiting |
p2_o10 |
1337-1356 |
Adverse-effects |
denotes |
nausea and vomiting |
p1_all16 |
1367-1381 |
Outcome |
denotes |
abdominal pain |
p2_o10 |
1367-1381 |
Adverse-effects |
denotes |
abdominal pain |
p1_all17 |
1395-1403 |
Outcome |
denotes |
diarrhea |
p2_o10 |
1395-1403 |
Adverse-effects |
denotes |
diarrhea |
p1_all18 |
1430-1448 |
Outcome |
denotes |
abdominal symptoms |
p2_o13 |
1661-1704 |
Other |
denotes |
duration of symptoms before hospitalization |
p1_all19 |
1661-1760 |
Outcome |
denotes |
duration of symptoms before hospitalization, mechanical ventilation and ICU and total hospital stay |
p2_o13 |
1706-1736 |
Other |
denotes |
mechanical ventilation and ICU |
p2_o13 |
1741-1760 |
Other |
denotes |
total hospital stay |
p1_all20 |
1813-1849 |
Outcome |
denotes |
Current smoking and smoking severity |
p2_o14 |
1813-1849 |
Mental |
denotes |
Current smoking and smoking severity |
p2_o15 |
2029-2038 |
Mortality |
denotes |
mortality |
p1_all21 |
2029-2059 |
Outcome |
denotes |
mortality and smoking severity |
p1_all22 |
2117-2174 |
Outcome |
denotes |
bilateral pulmonary infiltrates or unilateral infiltrates |
p1_all23 |
2338-2385 |
Outcome |
denotes |
radiology or increased bronchovascular markings |
p1_all24 |
2545-2575 |
Outcome |
denotes |
mean values of APACHE II score |
p2_o18 |
2545-2575 |
Other |
denotes |
mean values of APACHE II score |
p1_all25 |
2608-2618 |
Outcome |
denotes |
SOFA score |
p2_o19 |
2796-2798 |
Physical |
denotes |
PH |
p1_all26 |
2796-2832 |
Outcome |
denotes |
PH, PaO 2 , O 2 saturation and HCO 3 |
p2_o19 |
2800-2805 |
Physical |
denotes |
PaO 2 |
p2_o19 |
2808-2822 |
Physical |
denotes |
O 2 saturation |
p2_o19 |
2827-2832 |
Physical |
denotes |
HCO 3 |
p2_o20 |
3028-3037 |
Mortality |
denotes |
mortality |
p1_all27 |
3028-3049 |
Outcome |
denotes |
mortality and old age |
p1_all28 |
3063-3070 |
Outcome |
denotes |
obesity |
p2_o20 |
3063-3070 |
Physical |
denotes |
obesity |
p1_all29 |
3084-3101 |
Outcome |
denotes |
diabetes mellitus |
p2_o20 |
3084-3101 |
Physical |
denotes |
diabetes mellitus |
p1_all30 |
3115-3128 |
Outcome |
denotes |
renal failure |
p2_o20 |
3115-3128 |
Physical |
denotes |
renal failure |
p1_all31 |
3142-3164 |
Outcome |
denotes |
chronic heart diseases |
p2_o20 |
3142-3164 |
Physical |
denotes |
chronic heart diseases |
p2_o20 |
3174-3178 |
Physical |
denotes |
COPD |
p1_all32 |
3192-3202 |
Outcome |
denotes |
malignancy |
p2_o20 |
3192-3202 |
Physical |
denotes |
malignancy |
p1_all33 |
3216-3238 |
Outcome |
denotes |
kidney transplantation |
p2_o20 |
3216-3238 |
Physical |
denotes |
kidney transplantation |
p1_all34 |
3255-3270 |
Outcome |
denotes |
liver cirrhosis |
p2_o20 |
3255-3270 |
Physical |
denotes |
liver cirrhosis |
p2_o21 |
3405-3414 |
Mortality |
denotes |
mortality |
p2_o22 |
3480-3537 |
Adverse-effects |
denotes |
fever, cough, dyspnea, sore throat, runny nose and sputum |
p1_all35 |
3480-3538 |
Outcome |
denotes |
fever, cough, dyspnea, sore throat, runny nose and sputum. |
p1_all36 |
3602-3810 |
Outcome |
denotes |
Prolonged duration of symptoms before patients' hospitalization, prolonged duration of mechanical ventilation and hospital stay, bilateral radiological pulmonary infiltrates, and hypoxemic respiratory failure |
p2_o24 |
3612-3632 |
Physical |
denotes |
duration of symptoms |
p2_o24 |
3667-3729 |
Other |
denotes |
prolonged duration of mechanical ventilation and hospital stay |
p2_o24 |
3731-3775 |
Physical |
denotes |
bilateral radiological pulmonary infiltrates |
p2_o24 |
3781-3810 |
Physical |
denotes |
hypoxemic respiratory failure |
p2_o24 |
3849-3858 |
Mortality |
denotes |
mortality |